MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 147 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,058,000 | +257.0% | 248,815 | +126.3% | 0.01% | +166.7% |
| Q2 2020 | $3,658,000 | +25.9% | 109,934 | +2.9% | 0.00% | +50.0% |
| Q1 2020 | $2,905,000 | -5.7% | 106,833 | -31.5% | 0.00% | 0.0% |
| Q4 2019 | $3,079,000 | +134.1% | 156,033 | +53.9% | 0.00% | +100.0% |
| Q3 2019 | $1,315,000 | -8.6% | 101,388 | -12.2% | 0.00% | 0.0% |
| Q2 2019 | $1,438,000 | +16.9% | 115,507 | +36.4% | 0.00% | 0.0% |
| Q1 2019 | $1,230,000 | +162.8% | 84,654 | +99.7% | 0.00% | – |
| Q4 2018 | $468,000 | -82.5% | 42,399 | -58.2% | 0.00% | -100.0% |
| Q3 2018 | $2,667,000 | +210.5% | 101,372 | +141.1% | 0.00% | +100.0% |
| Q2 2018 | $859,000 | +8.2% | 42,039 | -3.9% | 0.00% | – |
| Q1 2018 | $794,000 | +61.4% | 43,756 | +24.0% | 0.00% | – |
| Q4 2017 | $492,000 | -38.2% | 35,290 | -18.0% | 0.00% | -100.0% |
| Q3 2017 | $796,000 | +37.0% | 43,037 | +25.2% | 0.00% | 0.0% |
| Q2 2017 | $581,000 | +100.3% | 34,363 | +58.6% | 0.00% | – |
| Q1 2017 | $290,000 | +63.8% | 21,671 | +84.2% | 0.00% | – |
| Q4 2016 | $177,000 | +73.5% | 11,767 | +34.8% | 0.00% | – |
| Q3 2016 | $102,000 | +3300.0% | 8,732 | +2810.7% | 0.00% | – |
| Q2 2016 | $3,000 | -95.7% | 300 | -96.1% | 0.00% | – |
| Q1 2016 | $69,000 | +53.3% | 7,631 | +138.3% | 0.00% | – |
| Q4 2015 | $45,000 | -85.8% | 3,202 | -83.9% | 0.00% | – |
| Q3 2015 | $318,000 | +69.1% | 19,872 | +130.3% | 0.00% | – |
| Q2 2015 | $188,000 | +0.5% | 8,630 | -30.5% | 0.00% | – |
| Q1 2015 | $187,000 | -54.8% | 12,426 | -63.9% | 0.00% | – |
| Q4 2014 | $414,000 | +34.0% | 34,436 | +23.0% | 0.00% | – |
| Q3 2014 | $309,000 | -40.9% | 27,987 | -35.8% | 0.00% | – |
| Q2 2014 | $523,000 | -7.3% | 43,622 | -14.9% | 0.00% | – |
| Q1 2014 | $564,000 | -51.0% | 51,270 | -24.2% | 0.00% | – |
| Q4 2013 | $1,150,000 | -31.1% | 67,674 | -43.3% | 0.00% | -100.0% |
| Q3 2013 | $1,669,000 | +0.7% | 119,282 | +8.5% | 0.00% | -33.3% |
| Q2 2013 | $1,657,000 | – | 109,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |